Literature DB >> 8982946

Late-onset holocarboxylase synthetase deficiency.

K M Gibson1, M J Bennett, W L Nyhan, C E Mize.   

Abstract

We report a 21-month-old female patient whose urine organic acid profile suggested a biotin utilization abnormality consistent with multiple carboxylase deficiency. For most previously reported patients, holocarboxylase synthetase deficiency has correlated with the early-onset variant of multiple carboxylase deficiency; conversely, biotinidase deficiency has been characteristic of the late-onset form. In vitro enzyme studies revealed that our patient suffered from holocarboxylase synthetase deficiency. We suggest that holocarboxylase synthetase deficiency should be considered in the differential diagnosis of older patients in whom there is suspicion of a defect in biotin metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982946     DOI: 10.1007/bf01799165

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

1.  Holocarboxylase synthetase deficiency: early diagnosis and management of a new case.

Authors:  A Fuchshuber; T Suormala; B Roth; M Duran; D Michalk; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

2.  The clinical spectrum of biotin-treatable encephalopathies in Saudi Arabia.

Authors:  O Dabbagh; J Brismar; G G Gascon; P T Ozand
Journal:  Brain Dev       Date:  1994-11       Impact factor: 1.961

3.  Metabolism of 1-13C-propionate in vivo in patients with disorders of propionate metabolism.

Authors:  B A Barshop; I Yoshida; A Ajami; L Sweetman; J A Wolff; F R Sweetman; C Prodanos; M Smith; W L Nyhan
Journal:  Pediatr Res       Date:  1991-07       Impact factor: 3.756

4.  Holocarboxylase synthetase deficiency: a treatable metabolic disorder masquerading as cerebral palsy.

Authors:  M Livne; K M Gibson; N Amir; G Eshel; O N Elpeleg
Journal:  J Child Neurol       Date:  1994-04       Impact factor: 1.987

  4 in total
  7 in total

Review 1.  Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review.

Authors:  Sahan P Semasinghe Bandaralage; Soheil Farnaghi; Joel M Dulhunty; Alka Kothari
Journal:  Pediatr Radiol       Date:  2016-01-11

2.  The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient.

Authors:  Joannie Hui; Eric Law; Christina Chung; Simon Fung; Patrick Yuen; Nelson Tang
Journal:  World J Pediatr       Date:  2011-08-27       Impact factor: 2.764

3.  Holocarboxylase synthetase deficiency: report of a case with onset in late infancy.

Authors:  E Touma; T Suormala; E R Baumgartner; B Gerbaka; H Ogier de Baulny; J Loiselet
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

4.  Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry.

Authors:  D D Hinson; R M Ross; S Krisans; J L Shaw; V Kozich; M O Rolland; P Divry; J Mancini; G F Hoffmann; K M Gibson
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

5.  Management of a patient with holocarboxylase synthetase deficiency.

Authors:  Johan L K Van Hove; Sagi Josefsberg; Cynthia Freehauf; Janet A Thomas; Le Phuc Thuy; Bruce A Barshop; Michael Woontner; Donald M Mock; Pei-Wen Chiang; Elaine Spector; Iván Meneses-Morales; Rafael Cervantes-Roldán; Alfonso León-Del-Río
Journal:  Mol Genet Metab       Date:  2008-10-29       Impact factor: 4.797

6.  Biotin and biotinidase deficiency.

Authors:  Janos Zempleni; Yousef I Hassan; Subhashinee Sk Wijeratne
Journal:  Expert Rev Endocrinol Metab       Date:  2008-11-01

7.  Holocarboxylase synthetase deficiency pre and post newborn screening.

Authors:  Taraka R Donti; Patrick R Blackburn; Paldeep S Atwal
Journal:  Mol Genet Metab Rep       Date:  2016-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.